Benazepril Hydrochloride + Spironolactone

Verify with FDA CVM →

63 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
3
Deaths Reported
480.0%
Death Rate

Active Ingredients

Benazepril HydrochlorideSpironolactone

Administration Routes

OralUnknown

Species Affected

Dog 42
Unknown 21

Most Affected Breeds

Unknown 21
Beagle 11
Crossbred Canine/dog 5
Chihuahua 5
Mixed (Dog) 3
Retriever - Golden 2
Spaniel - Cocker American 2
Shih Tzu 2
Spaniel - King Charles Cavalier 2
Spitz - German Pomeranian 1

Most Reported Reactions

Vomiting 12
Tablets, Abnormal 7
Diarrhoea 6
Loose stool 5
Closure, Abnormal 5
Product defect, product difficult to use/handle (see also 'Drug device difficult to use/handle') 5
Anorexia 4
Lack of efficacy - NOS 4
Difficulty of Use 4
Emesis 3
Appearance, Abnormal 3
Caps, Abnormal 3

Outcome Breakdown

Recovered/Normal
23 (54.8%)
Ongoing
12 (28.6%)
Outcome Unknown
4 (9.5%)
Died
2 (4.8%)
Euthanized
1 (2.4%)

Data Summary

Metric Value
Total adverse event reports 63
Reports involving death 3
Case-fatality rate (reported events) 480.0%
Distinct species in reports 2
Distinct breeds in reports 19
Distinct reactions reported 20
Active ingredients on file 2

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Benazepril Hydrochloride + Spironolactone Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 63 adverse event reports referencing Benazepril Hydrochloride + Spironolactone, including 3 reports in which the animal died — a 480.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Benazepril Hydrochloride, Spironolactone. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Benazepril Hydrochloride + Spironolactone reports are Dog (42 reports), Unknown (21 reports), with Dog accounting for the largest share. Within those species, Unknown (21), Beagle (11), Crossbred Canine/dog (5) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Benazepril Hydrochloride + Spironolactone are Vomiting (12), Tablets, Abnormal (7), Diarrhoea (6), Loose stool (5). Of the 42 reports with a coded outcome, Recovered/Normal is the leading category at 54.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Benazepril Hydrochloride + Spironolactone.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial